Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
268.50
-13.45 (-4.77%)
At close: Mar 9, 2026, 4:00 PM EDT
268.50
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:30 PM EDT

Bio-Rad Laboratories Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,3458,1789,2029,20812,44522,616
Market Cap Growth
-7.97%-11.13%-0.07%-26.01%-44.97%30.00%
Enterprise Value
7,1897,9858,8698,96012,00021,927
Last Close Price
268.50302.99328.51322.89420.49755.57
PE Ratio
9.6710.88-5.03-14.80-3.455.37
Forward PE
26.84-----
PS Ratio
2.843.173.593.454.447.74
PB Ratio
0.991.101.401.051.291.65
P/TBV Ratio
0.981.111.411.081.301.67
P/FCF Ratio
19.619.0212.3515.53152.5142.22
P/OCF Ratio
13.807.6810.1112.2864.0233.78
EV/Sales Ratio
2.783.093.463.354.287.50
EV/EBITDA Ratio
16.6637.5621.0918.5224.8643.82
EV/EBIT Ratio
27.01169.1632.9726.5324.8643.82
EV/FCF Ratio
19.198.8111.9115.11147.0640.93
Debt / Equity Ratio
0.180.180.200.160.140.01
Debt / EBITDA Ratio
6.516.513.272.912.880.45
Debt / FCF Ratio
1.531.531.852.3717.010.42
Net Debt / Equity Ratio
-0.02-0.02-0.04-0.02-0.04-0.05
Net Debt / EBITDA Ratio
-0.73-0.73-0.69-0.43-0.85-1.30
Net Debt / FCF Ratio
-0.17-0.17-0.39-0.35-5.00-1.22
Asset Turnover
0.260.260.240.210.180.19
Inventory Turnover
1.661.661.541.661.912.15
Quick Ratio
3.873.874.534.024.031.91
Current Ratio
5.625.626.485.835.552.92
Return on Equity (ROE)
10.84%10.84%-24.09%-6.94%-31.14%36.11%
Return on Assets (ROA)
0.59%0.59%3.01%3.27%3.79%3.96%
Return on Invested Capital (ROIC)
0.72%0.72%3.65%3.88%4.25%4.34%
Return on Capital Employed (ROCE)
0.50%0.50%2.60%2.73%3.21%3.40%
Earnings Yield
10.35%9.19%-19.90%-6.76%-28.96%18.64%
FCF Yield
5.10%11.09%8.09%6.44%0.66%2.37%
Buyback Yield / Dilution
3.42%3.42%2.00%4.45%1.59%0.13%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q